Atypical Chronic Myeloid Leukemia in a Patient with Aplastic Anemia

Acta Haematol. 2019;142(3):185-186. doi: 10.1159/000497137. Epub 2019 May 21.

Affiliations

¹ Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy, santopietro@bce.uniroma1.it.
² Hematology Unit, IRCCS-Istituto Giannina Gaslini, Genoa, Italy.
³ Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
⁴ Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

PMID: 31112981
DOI: 10.1159/000497137

No abstract available

Publication types

Case Reports

MeSH terms

Adolescent
Anemia, Aplastic* / diagnosis
Anemia, Aplastic* / drug therapy
Anemia, Aplastic* / genetics
Antilymphocyte Serum / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Cyclosporine / administration & dosage
Cytarabine / administration & dosage
Etoposide / administration & dosage
Fatal Outcome
Granulocyte Colony-Stimulating Factor / administration & dosage
Humans
Imidazoles / administration & dosage
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / diagnosis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / genetics
Male
Methylprednisolone / administration & dosage
Prednisolone / administration & dosage
Pyridazines / administration & dosage

Substances

Antilymphocyte Serum
Imidazoles
Pyridazines
Cytarabine
Granulocyte Colony-Stimulating Factor
ponatinib
Etoposide
Cyclosporine
Prednisolone
Methylprednisolone